These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23880830)

  • 1. Riboswitch control of induction of aminoglycoside resistance acetyl and adenyl-transferases.
    He W; Zhang X; Zhang J; Jia X; Zhang J; Sun W; Jiang H; Chen D; Murchie AI
    RNA Biol; 2013 Aug; 10(8):1266-73. PubMed ID: 23880830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riboswitch control of aminoglycoside antibiotic resistance.
    Jia X; Zhang J; Sun W; He W; Jiang H; Chen D; Murchie AI
    Cell; 2013 Jan; 152(1-2):68-81. PubMed ID: 23332747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integron-Derived Aminoglycoside-Sensing Riboswitches Control Aminoglycoside Acetyltransferase Resistance Gene Expression.
    Wang S; He W; Sun W; Zhang J; Chang Y; Chen D; Murchie AIH
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An aminoglycoside sensing riboswitch controls the expression of aminoglycoside resistance acetyltransferase and adenyltransferases.
    Chen D; Murchie AI
    Biochim Biophys Acta; 2014 Oct; 1839(10):951-8. PubMed ID: 24631585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside riboswitch control of the expression of integron associated aminoglycoside resistance adenyltransferases.
    Zhang J; Liu G; Zhang X; Chang Y; Wang S; He W; Sun W; Chen D; Murchie AIH
    Virulence; 2020 Dec; 11(1):1432-1442. PubMed ID: 33103573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riboswitch regulation of aminoglycoside resistance acetyl and adenyl transferases.
    Jia X; Zhang J; Sun W; He W; Jiang H; Chen D; Murchie AI
    Cell; 2013 Jun; 153(7):1419-20. PubMed ID: 23791168
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of enzymes that cause resistance to aminoglycosides antibiotics.
    Serpersu EH; Ozen C; Wright E
    Methods Mol Med; 2008; 142():261-71. PubMed ID: 18437320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying aminoglycoside modification by the acetyltransferase class of resistance-causing enzymes via microarray.
    Barrett OJ; Pushechnikov A; Wu M; Disney MD
    Carbohydr Res; 2008 Nov; 343(17):2924-31. PubMed ID: 18774127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of aminoglycoside resistance genes in integron cassettes is not controlled by riboswitches.
    Hipólito A; García-Pastor L; Blanco P; Trigo da Roza F; Kieffer N; Vergara E; Jové T; Álvarez J; Escudero JA
    Nucleic Acids Res; 2022 Aug; 50(15):8566-8579. PubMed ID: 35947699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aminoglycoside resistance in gramnegative pathogens of nosocomial infections in Russia].
    Reshed'ko GK
    Antibiot Khimioter; 2004; 49(5):11-23. PubMed ID: 15573898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.
    Shaw KJ; Rather PN; Hare RS; Miller GH
    Microbiol Rev; 1993 Mar; 57(1):138-63. PubMed ID: 8385262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside resistance resulting from tight drug binding to an altered aminoglycoside acetyltransferase.
    Magnet S; Smith TA; Zheng R; Nordmann P; Blanchard JS
    Antimicrob Agents Chemother; 2003 May; 47(5):1577-83. PubMed ID: 12709325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene
    Plattner M; Gysin M; Haldimann K; Becker K; Hobbie SN
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.
    Shakil S; Khan R; Zarrilli R; Khan AU
    J Biomed Sci; 2008 Jan; 15(1):5-14. PubMed ID: 17657587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities.
    Böhm ME; Razavi M; Marathe NP; Flach CF; Larsson DGJ
    Microbiome; 2020 Mar; 8(1):41. PubMed ID: 32197644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets for design of novel inhibitors to circumvent aminoglycoside resistance.
    Jana S; Deb JK
    Curr Drug Targets; 2005 May; 6(3):353-61. PubMed ID: 15857293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of vertilmicin to modifications by three types of recombinant aminoglycoside-modifying enzymes.
    Yuan M; Han H; Li CR; Yang XY; Li GQ; Cen S; Kang XX; Si SY; Jiang JD; You XF
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3950-3. PubMed ID: 21646489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New integron-associated gene cassette encoding a 3-N-aminoglycoside acetyltransferase.
    Levings RS; Partridge SR; Lightfoot D; Hall RM; Djordjevic SP
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1238-41. PubMed ID: 15728939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular understanding of aminoglycoside action and resistance.
    Jana S; Deb JK
    Appl Microbiol Biotechnol; 2006 Mar; 70(2):140-50. PubMed ID: 16391922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
    Fernández-Martínez M; Miró E; Ortega A; Bou G; González-López JJ; Oliver A; Pascual A; Cercenado E; Oteo J; Martínez-Martínez L; Navarro F;
    Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.